Literature DB >> 6491620

The relationship of lipoprotein (a) (Lp(a)) to risk factors of coronary heart disease: initial results of the prospective epidemiological study on company employees in Westfalia.

H Schriewer, G Assmann, M Sandkamp, H Schulte.   

Abstract

Lp(a) concentrations were determined in 987 male and 477 female company employees in Westfalia, in the age range 17-70 years. These values were then related to age and to the following risk factors: obesity, smoking, hypertension, hypertriglyceridaemia, hypercholesterolaemia, hyperbetalipoproteinaemia, hypoalphalipoproteinaemia, hyperglycaemia and hyperuricaemia. The Lp(a) values showed a similar markedly skewed distribution for both men and women. The median for men was 0.039 g/l, for women 0.050 g/l. In both sexes only about 25% of all Lp(a) values were above 0.10 g/l. Raised Lp(a) values (greater than 0.30 g/l) were found in 6.5% of males and in 6.1% of females. A significantly higher frequency of raised Lp(a) values (greater than 0.30 g/l) was found in: post-menopausal women (11.3% as against 4.1%, p less than 0.01); females with hypercholesterolaemia (19.0% when cholesterol values were greater than or equal to 6.73 mmol/l, 10.8% when cholesterol values were between 5.70-6.72 mmol/l, 3.0% when cholesterol values were less than 5.70 mmol/l, p less than 0.001); and females with hyperbetalipoproteinaemia (22.6% when LDL cholesterol values were greater than or equal to 4.92 mmol/l, 5.0% when LDL cholesterol values were less than 4.92 mmol/l, p less than 0.001). 12.0% of men with hypoalphalipoproteinaemia (HDL cholesterol values less than 0.907 mmol/l) had Lp(a) values greater than 0.30 g/l, as against 5.5% of men with HDL cholesterol values greater than or equal to 0.907 mmol/l (p less than 0.01). This percentage rate increased to 16.9% when hypertriglyceridaemia (greater than or equal to 2.28 mmol/l triglycerides) was also present. All other risk factors which were examined and their combinations had no significant influence on the prevalence of raised Lp(a) concentrations.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6491620     DOI: 10.1515/cclm.1984.22.9.591

Source DB:  PubMed          Journal:  J Clin Chem Clin Biochem        ISSN: 0340-076X


  8 in total

1.  Increased incidence of coronary disease in people with impaired glucose tolerance: link with increased lipoprotein(a) concentrations?

Authors:  M Davies; G Rayman; J Day
Journal:  BMJ       Date:  1992-06-20

2.  Morphological detection and quantification of lipoprotein(a) deposition in atheromatous lesions of human aorta and coronary arteries.

Authors:  A Niendorf; M Rath; K Wolf; S Peters; H Arps; U Beisiegel; M Dietel
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

3.  Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.

Authors:  C Sandholzer; E Boerwinkle; N Saha; M C Tong; G Utermann
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

4.  Lipoprotein (a), low-density, intermediate-density lipoprotein, and blood pressure in a young male population.

Authors:  A Steinmetz; A Kirklies; G Schlosser; W Cassel; J H Peter; K Ehlenz; J R Schäfer; P V Wichert; H Kaffarnik
Journal:  Clin Investig       Date:  1993-02

5.  Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma.

Authors:  P Henriksson; B Angelin; L Berglund
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

Review 6.  Physical activity and lipoprotein lipid disorders.

Authors:  A Berg; I Frey; M W Baumstark; M Halle; J Keul
Journal:  Sports Med       Date:  1994-01       Impact factor: 11.136

7.  Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus.

Authors:  C A DeMeester; X Bu; R J Gray; A J Lusis; J I Rotter
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

8.  Relation of cardiovascular risk factors to atherosclerosis in type III hyperlipoproteinemia.

Authors:  G Feussner; A Wagner; R Ziegler
Journal:  Hum Genet       Date:  1993-09       Impact factor: 4.132

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.